Cumberland Pharmaceuticals Pitch Deck

Company Overview Specialty pharmaceutical company Portfolio of six FDA approved products Promoted by two national sales forces Several near-term catalysts for new growth opportunities . • Vibativ post-acquisition integration and market expansion Next Generation Caldolor product • RediTrex methotrexate product line 3 Five Phase II products in development with upcoming study milestones Proven record of successful product development and product acquisition Strong financial position and positive net cash flows from operations

View entire presentation